Brief: Inspira Technologies Agrees To Conduct Clinical Study Of HYLA Blood Sensor
14/12/2022 14:39
Dec 14 (Reuters) - Inspira Technologies Oxy BHN Ltd
IINN.O :
* INSPIRA™ TECHNOLOGIES SIGNS AGREEMENT TO CONDUCT CLINICAL
STUDY
OF HYLA™ BLOOD SENSOR
Source text for Eikon: ID:nPn4M8t9da
Further company coverage: IINN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Qtrex Quantum
See all newsBrief: Qtrex Announces Receipt Of Nasdaq Notification Regarding Minimum Bid Price Requirement
Brief: Qtrex Quantum Ltd In Discussions With A US Department Of Defense’S Research Laboratory To Establish A Joint Quantum Development Program
Brief: Qtrex Quantum - Offers Up To 6.8 Million Ordinary Shares For Resale By Selling Shareholder - SEC Filing
Brief: Qtrex Expands Into Quantum Processor Interface With Single-Build Cryogenic Chip Carrier
NASDAQ RESUMED AT 11:03 AM